Drugs / YOLT-204
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 0 | NCT07190001 | Sep 2025 → Apr 2027 expected | inherited hemoglobinopathy | Guangzhou Women and Children's Medical Center | Not yet recruiting | No outcome recorded |
| Phase 0 | NCT06678165 | Dec 2024 → Jun 2026 overdue | beta thalassemia | First Affiliated Hospital of Guangxi Medical University | Not yet recruiting | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | YOLT-204 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06678165 ↗ |